There are 2949 resources available
546P - Innovative medicine in rare cancer: Perceived value of adaptive trials and surrogate endpoints for clinical decisions
Presenter: Andriy Krendyukov
Session: E-Poster Display
Resources:
Abstract
547P - Rucaparib + sacituzumab govitecan (SG): Initial data from the phase Ib/II SEASTAR study (NCT03992131)
Presenter: Timothy Yap
Session: E-Poster Display
Resources:
Abstract
548P - Molecular pre-screening using comprehensive gene panels offered by clinical trials (CT)
Presenter: Ivan Victoria Ruiz
Session: E-Poster Display
Resources:
Abstract
549P - Identification of RET rearrangement in 12888 Chinese lung cancer patients by next-generation sequencing (NGS)
Presenter: Yuning Han
Session: E-Poster Display
Resources:
Abstract
550P - Preclinical characterization of CPL304110 as a potential selective inhibitor of fibroblast growth factors 1/2/3 in solid cancers
Presenter: Delfina Popiel
Session: E-Poster Display
Resources:
Abstract
551P - Phase I study of lurbinectedin in Japanese patients with pretreated advanced tumours: Final results
Presenter: Shunji Takahashi
Session: E-Poster Display
Resources:
Abstract
552P - Safety and efficacy of long-term exposure (LTE) to tislelizumab in Chinese patients with advanced solid tumours
Presenter: Lin Shen
Session: E-Poster Display
Resources:
Abstract
553P - Activity of trastuzumab and pertuzumab (HP) in patients with non-breast/gastroesophgeal HER2-amplified tumours: Results of the NCI-MATCH trial (EAY131) subprotocol J
Presenter: Roisin Connolly
Session: E-Poster Display
Resources:
Abstract
554P - Selinexor in combination with carboplatin and paclitaxel in patients with advanced or metastatic solid tumours: Results of an open label, single-center, multi-arm phase Ib study
Presenter: Kyaw Thein
Session: E-Poster Display
Resources:
Abstract
555P - Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) + durvalumab (D) in advanced solid tumours (AST): Dose finding results
Presenter: Anthony Gonçalves
Session: E-Poster Display
Resources:
Abstract